Several pharmaceutical companies awaiting a decision from U.S. authorities on their drug applications are set to get them ...

An update from Genmab ( ($GMAB) ) is now available. On November 10, 2025, Genmab A/S announced a proposed private offering of $1.5 billion in ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

In its most recent quarterly report, Genmab A/S posted strong results, with third quarter sales reaching US$1.02 billion and net income more than doubling compared to a year earlier. The company also ...

Genmab (GMAB) and Sonic Automotive (SAH) are climbing 5% and 3%, respectively, after investment banks issued favorable notes about the stocks. Leerink Partners raised its rating on GMAB to Outperform ...

On Saturday, Genmab A/S (NASDAQ:GMAB) revealed updated data from cohort B2 of the Phase 1/2 RAINFOL-01 trial evaluating rinatabart sesutecan (Rina-S) in heavily pretreated patients with advanced ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other ...

Genmab AS (GMAB) reports a 21% revenue increase and a 52% rise in operating profit, driven by strong sales and strategic advancements.

LANSING, Mich.--(BUSINESS WIRE)--Jackson National Life Insurance Company ® (Jackson ®), the main operating subsidiary of Jackson Financial Inc. 1 (NYSE: JXN), today launched Principal Guard, an add-on ...